In order to validate the effects of HDAC inhibition on ER stress induction, we applied quisinostat on a non‐small cell lung cancer cell line A549, since aberrant expressions of HDACs are observed in lung cancer, and several HDAC inhibitors are tested in clinical trials for the treatment of lung cancer [20]. The gene discussed is HDAC9; the disease is lung carcinoma.